日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase 1/2a, open-label, multicenter study of RM-1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma

RM-1929 光免疫疗法治疗局部复发性头颈部鳞状细胞癌的 1/2a 期、开放标签、多中心研究

Cognetti, David M; Johnson, Jennifer M; Curry, Joseph M; Kochuparambil, Samith T; McDonald, Darren; Mott, Frank; Fidler, Mary J; Stenson, Kerstin; Vasan, Nilesh R; Razaq, Mohammad A; Campana, John; Ha, Patrick; Mann, Grace; Ishida, Kosuke; Garcia-Guzman, Miguel; Biel, Merrill; Gillenwater, Ann M

Efficacy and Safety of Avelumab Treatment in Patients With Advanced Unresectable Mesothelioma: Phase 1b Results From the JAVELIN Solid Tumor Trial

Avelumab治疗晚期不可切除间皮瘤患者的疗效和安全性:JAVELIN实体瘤试验的1b期结果

Hassan, Raffit; Thomas, Anish; Nemunaitis, John J; Patel, Manish R; Bennouna, Jaafar; Chen, Franklin L; Delord, Jean-Pierre; Dowlati, Afshin; Kochuparambil, Samith T; Taylor, Matthew H; Powderly, John D; Vaishampayan, Ulka N; Verschraegen, Claire; Grote, Hans Juergen; von Heydebreck, Anja; Chin, Kevin; Gulley, James L

Simultaneous modulation of the intrinsic and extrinsic pathways by simvastatin in mediating prostate cancer cell apoptosis

辛伐他汀通过同时调节内在和外在途径来介导前列腺癌细胞凋亡

Goc, Anna; Kochuparambil, Samith T; Al-Husein, Belal; Al-Azayzih, Ahmad; Mohammad, Shuaib; Somanath, Payaningal R